CRISPR-and-Cas-Gene-Market

Smorkane26 Jan, 2025Business

The Brainy Insights estimates that the USD 3.16 billion in 2023 global CRISPR and Cas Gene market will reach USD 15.60 billion by 2033. Cell and gene therapy is rapidly evolving, with CRISPR-Cas gene editing playing a central role in therapeutic development. Opportunities exist for developing CRISPR-modified cell therapies, including CAR-T cells, stem cell therapies, and engineered immune cells, for personalized and targeted treatments of cancer and genetic diseases.

Recent Profiles

Game Bai Doi Thuong

Game Bai Doi Thuong

View Profile

Business Manager

Business Manager

View Profile

Applifix Appliance Repair

Applifix Appliance Repair

View Profile

Business Manager

Business Manager

View Profile

Business Manager

Business Manager

View Profile

PellegrinCorp

Pellegrincorp

View Profile

Casino Fără Depunere

Casino Fără Depunere

View Profile

789WIN

789win

View Profile

BONGDALU

Bongdalu

View Profile